Fluid restriction for treatment of symptomatic patent ductus arteriosus in preterm infants

0Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of fluid restriction for symptomatic patent ductus arteriosus (PDA) in preterm infants. To determine if fluid restriction (parenterally, enterally, or both) with or without diuretics reduces morbidity and mortality in preterm infants with a symptomatic PDA.

Cite

CITATION STYLE

APA

MacLellan, A., Cameron, A. J., Cooper, C., & Mitra, S. (2022). Fluid restriction for treatment of symptomatic patent ductus arteriosus in preterm infants. Cochrane Database of Systematic Reviews, 2022(12). https://doi.org/10.1002/14651858.CD015424

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free